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The present study was planned to evaluate the toxic effects of ribavirin on the
reproductive parameters in the male Wistar rat. Rats (11–13 weeks old) were
treated with 5 injections (i.p.) of 20, 100 or 200 mg/kg/day ribavirin at intervals of
24 h. The testes were processed for histopathological analysis on days 14, 35, 70
and 105 after the last exposure. The parameters studied were body weight, the
weights of the testis, epididymis, seminal vesicle and prostate, seminiferous tubu-
lar diameter (STD), epithelial height (SE), epithelial sloughing, incidence of stage
XIV tubules, sperm abnormality and total serum level of testosterone. Data were
analysed by ANOVA and the Bonferroni post hoc test for significances between
different groups. There was a decrease in body weight and organ weights,
excluding those of the testis and epididymis, against control at higher dose-levels.
Ribavirin induced the formation of vacuoles, gaps and sloughing of the seminifer-
ous epithelium. The STD, SE and the incidences of stage XIV tubules decreased on
days 14 and 35. Ribavirin also induced the formation of sperm with microcephaly
and cephalocaudal junction defects, with or without fibrils jetting out. All these
morphological defects recovered to control limit by day 105. The serum level of
testosterone was decreased at all dose-levels and time points, although recovery
had started by day 105. In conclusion, ribavirin is gonadotoxic in male rats but the
effects are reversible after a period of 105 days. However, the endocrine-disrupting
properties of ribavirin persist beyond this period.
Key words: antiviral drugs, germ cells, testosterone, testis,
cytotoxicity, gonadotoxicity
INTRODUCTION
Ribavirin (1-b-D-ribofuranosyl-1, 2, 4 triazole-3-
-carboxamide) is a unique antiviral drug that is clini-
cally effective against unrelated viruses, including fam-
ilies of paramyxoviruses, flaviviruses, picornaviruses,
orthomyxoviruses, arena viruses and reoviruses [4].
Although its mechanism of action is uncertain, it is
known to inhibit the activity of inosine mono-
phosphate dehydrogenase [9]. The toxicity profile of
this drug, especially on the genetic material and re-
productive system, has not been properly understood.
Ribavirin has acted as a genotoxic agent in the mouse
bone marrow [19] although other studies have not
considered it as severe a mutagen as other antiviral
66
Folia Morphol., 2005, Vol. 64, No. 2
drugs [18]. Reports are available, which reveal its
toxicity on haematological parameters and, there-
fore, induced abnormal clinical conditions in both
animals and humans [1]. Recently, the suppressing
effects of ribavirin at dose-levels of 20–200 mg/kg
have been demonstrated on the sperm-population
in the epididymis of the rat in a dose-dependent and
time-dependent pattern [15]. This result was due to
the toxicity of the drug on germ cells, exerted in terms
of inhibition of cell renewal and acceleration of cell
death akin to apoptosis [6]. Evaluation of mutage-
nicity by a sperm morphology test in the rat at  dose-
levels of 20–200 mg/kg revealed an increased inci-
dence of abnormal sperm, probably as a result of
mutations, although these effects were transient
[16]. Serious effects, such as microcephaly and mid-
piece defects in sperm were not evaluated in the
above study. Hoffmann et al. [12] reported that rib-
avirin could not induce any dominant lethal muta-
tions, hence concluding that ribavirin had no impact
whatsoever on the fertility of the rat. In the light of
the above findings, the present study has been un-
dertaken to evaluate the effect of ribavirin on the
reproductive parameters in the rat.
MATERIAL AND METHODS
Animals
Male Wistar rats (11–13 weeks old) were housed
in polypropylene cages with paddy husk bedding
under controlled temperature and humidity. They
were fed on laboratory chow and tap water ad libi-
tum. All experiments were conducted in accordance
with the institutional ethical committee guidelines
and those of the Government of India.
Treatment and tissue processing
The rats were segregated into 16 groups of 5 rats
each. Of these, 4 groups served as controls, receiving
only water. Ribavirin (Virazole, ICN Pharmaceuticals,
Inc., California, Lot No. 94 J 02) was administered
(i.p.) at dose-levels of 20, 100 or 200 mg/kg in such
a way that 4 groups received 20 mg/kg, another
4 groups received 100 mg/kg, and the remaining
4 groups received 200 mg/kg, for 5 consecutive days
at intervals of 24 h. The dose selection and the route
of exposure were based on earlier studies [15, 16, 19],
and 20 mg/kg was an antiviral dose, whereas the
other doses used were higher to test the adverse
effects at higher dose-levels. On days 14, 35, 70 and
105 following the last exposure 4 sample points were
selected, based on a previous study [15]. On each of
the days assigned for sacrificing the rats one con-
trol group and one group from each of the three
dose-levels was randomly selected, each group con-
sisting of 5 animals. The animals were anesthetised
(Pentabarbitone sodium, 45 mg/kg, Sigma Chemi-
cals), and the thoracic wall was excised to expose
the heart. The blood was collected from the heart
for the evaluation of testosterone in the serum (vide
infra). The testis was fixed in Bouin’s fluid [20] (on
all sampling points), and the epididymis, seminal
vesicle and prostate (at day 35 after exposure only)
were fixed in 10% buffered formalin, and then pro-
cessed for paraffin embedding [5]. The body weights
of the animals were measured up to day 14 and the
organ weights were measured on day 35, with the
exception of the testis, which was measured on all
sampling points.
Sperm morphology test
The epididymes of the control and treated rats
(from the 35-day sample only) were minced in 1 ml
of phosphate buffered saline (pH 7.2) on day 35
after the last exposure. The suspension was then
filtered through 80 µ nylon mesh and the filtrate
was stained with 1% eosin Y and smears were pre-
pared on clean glass slides [16]. In all 1,000 sperm
per animal were examined and sperm with micro-
cephaly and those with cephalocaudal bending
with or without fibrils jetting out were counted
and expressed as percentage incidence.
Staining and histopathological analysis
Sections of 5 micron in thickness (Jung-Biocut,
Leica, 2035, Germany) were stained with haematoxylin
and eosin and also by PAS-haematoxylin [5]. Testes
were analysed for qualitative changes by observing
the vacuoles, gaps, epithelial sloughing and abnor-
mal cells in the epithelium. The seminiferous tubule
diameter (STD) and epithelial height (SE) were mea-
sured using an ocular micrometer, calibrated with
the stage micrometer. The stage VII tubules only were
selected to avoid any stage-dependent variations in
morphometrical values. In each testis 10 transverse-
ly cut seminiferous tubules were selected for mea-
suring STD and SE. In each tubule both maximum
and minimum diameters were measured and then
their average taken. In the same tubule the SE was
measured from the basement membrane to the sur-
face of the epithelium at 2 locations and their aver-
age taken. Finally, the representative values of STD
or SE for each animal were obtained by taking the
averages of 10 measurements each. In each testis
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100 tubular sections were screened continuously and
tubules that were encountered with epithelial slough-
ing and stage XIV of the seminiferous cycle were sub-
sequently recorded to express their percentage inci-
dence [11]. In each testis 10 inter-tubular spaces were
selected and the number of Leydig cells was count-
ed. An average of 10 counts served as the number
of Leydig cells/inter-tubular space for that animal.
Estimation of testosterone level
Total serum level of testosterone was estimated
by Automated Chemiluminescence System (ACS 180;
Chiron Diagnostics Corporation, East Walpole, USA)
in accordance with the manufacturer’s instructions.
Statistical analysis
The data were expressed as means ± SD or SEM
for each group (5 animals per group) and subject-
ed to statistical analysis by one-way Analysis of
Variance for differences between groups. Multi-
ple comparisons were performed by the Bonfer-
onni post hoc test. The level of significance was
set at p < 0.05.
RESULTS
There were no qualitative changes in the control
testes and they showed normal cell associations in
the seminiferous tubules (Fig. 1A). Occasionally, the
gaps (Fig. 1B) or vacuoles (Fig. 1C) were seen in the
seminiferous epithelium of treated testes on days
35 and 70. Testes from the treated rats showed ep-
ithelial sloughing (Fig. 1D) and dark basophilic cells
on days 14 and 35. Ribavirin caused neither the for-
mation of multinucleated cells nor tubular atrophy
at any dose-level or time point. Body weight had
decreased by day 6 at 100 mg/kg (p < 0.05) and on
day 14 at two higher dose-levels (p < 0.05–0.01;
Fig. 2). On the other hand, there was no significant
effect on the weights of the testis or the epididymis
at any of the dose-levels or sampling points tested
(data not shown). The weights of the seminal vesicles
and prostate decreased (p < 0.01–0.001) at two high-
er dose-levels in a dose-dependent pattern (Table 1).
Figure 1. Effect of ribavirin on the rat testis. A. A testicular sec-
tion from a control rat showing normal cell association. B. A sec-
tion of a testis from a rat treated with 20 mg/kg on day 35 show-
ing gaps (arrows) in the epithelium, H and E; A and B — scale
bar = 93 µm; C. A section of a testis from 100 mg/kg on day 35
showing a large vacuole (V) in the epithelium; D. A section of
a testis from a rat treated with 200 mg/kg on day 35 showing
sloughed germ cells in the lumen (Sg) and the gaps in the epithe-
lium (arrow); PAS-haematoxylin; C and D — scale bar = 23 µm.
A B
C D
Figure 2. Effect of ribavirin on the body weight of animals treat-
ed with ribavirin and sacrificed on day 14. Data are represented
as means ± SD from 5 animals per group. Inter-group differences
were significant on days 6 (p < 0.05) and 14 (p < 0.01).
After multiple comparisons there were no differences between
control and treated or between treated animals on day 0. On day
6 control vs. 100 mg/kg (p < 0.05) and on day 14 control vs.
100 mg/kg (p < 0.05) and control vs. 200 mg/kg (p < 0.01)
were significant.
Table 1. Effect of ribavirin on organ weights in the rat on
day 35 after the last exposure. Data are represented as
means ± SD from 5 animals per group. Inter-group differ-
ences were significant (p < 0.05–0.01)
Groups Seminal vesicle [g] Prostate [g]
Control 0.949±0.05 0.836 ±0.04
20 mg/kg 0.931±0.03 0.837 ±0.01
100 mg/kg 0.838±0.02* 0.612 ±0.01**
200 mg/kg 0.701±0.03** 0.591 ±0.02**
*p < 0.01, **p < 0.001 control versus treated
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The STD decreased in the 20 mg/kg group on days
14 and 35 (p < 0.01) and the two higher doses in-
creased it on day 14 but had decreased it by day 35
(Fig. 3). The two higher doses decreased the SE on
day 35 in a dose-dependent pattern (p < 0.05–0.01)
and it was further decreased on day 70 at 100 mg/kg,
although without any effect on day 105 (Fig. 4). The
incidences of stage XIV tubules significantly de-
creased at all three dose-levels on days 14 and 35
(p < 0.05–0.01; Table 2), and only the two higher
doses imparted similar effects on day 70. This effect
was exerted in a dose-dependent pattern on days
14 and 35, with greater toxicity at the latter sample
time. The incidences of tubules with epithelial slough-
ing increased in a dose-dependent pattern and the
maximum damage was observed on day 70. This
morphological defect showed a complete recovery
by day 105 (Table 2). Ribavirin induced the forma-
tion of sperm with microcephaly and cephalocaudal
junction defects at two higher dose-levels (Table 3).
Some sperm also showed the fibrils jetting out of
the bending at the cephalocaudal junctions (Fig. 5).
The Leydig cells were fewer in number in the treat-
ed testes those in the control. Their decrease in num-
Figure 3. Effect of ribavirin on STD [µm] in the rat testis. Data
are represented as means ± SEM from 5 animals per group.
The effect was significant against respective controls on days
14 and 35 (p < 0.01) and not at other two sampling times.
Inter-group differences were significant from day 14 to day 35
(p < 0.01) and until day 70 (p < 0.05). However, there were no
differences between the groups on day 105.
Figure 4. Effect of ribavirin on SE [µm] of seminiferous tubules in
the rat testis. Data are represented as means ± SEM from
5 animals per group. The SE was decreased at 100 (p < 0.05)
and 200 mg/kg (p < 0.01) on day 35 and on day 70 (p < 0.01)
against respective controls. Inter-group differences were signifi-
cant on day 35 (p < 0.05) and day 70 (p < 0.01), while at the
other two sampling times there were no significant differences.
ber was dose-dependent at all sample points and
there was no recovery to the control limit even on
day 105 (Fig. 6). Ribavirin decreased the serum level
of testosterone in a dose-dependent pattern at all
dose-levels and sampling points (p < 0.05–0.01). The
lowest serum level of testosterone was observed on
day 70 in the 200 mg/kg dose group (Fig. 7). The
hormone level had shown some recovery by day 105
when compared to previous sampling points, but
maintained significant differences with the control.
DISCUSSION
We have observed decreased food and water in-
take during and after the treatment, especially at
higher dose-levels, leading to a significant decrease
in the body weight of the animals. The appearance
of vacuoles in the seminiferous epithelium indicates
that the drug caused damage to the Sertoli cell struc-
ture in terms of dilatation of the endoplasmic reticu-
lum [7], although a few investigators are of the opin-
ion that the vacuoles indicate a non-specific injury,
occurring during unrelated conditions of testicular
damage [3]. The gaps in the seminiferous epitheli-
um appeared as a result of the removal of germ cells
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Table 3. The effect of ribavirin on sperm abnormalities in the rat on day 35 after the last exposure. Data are represented
as means ± SD from 5 animals per group. Inter-group differences are significant (p < 0.05–0.01)
Groups Microcephaly c-c bending without fibrils c-c bending with fibrils
Control 0.60 ± 0.89 2.60 ± 1.82 3.20 ± 1.30
20 mg/kg 0.80 ± 0.84 7.60 ± 2.41* 6.40 ± 2.79*
100 mg/kg 10.60 ± 2.70** 14.20 ± 1.92** 6.20 ± 2.04*
200 mg/kg 12.00 ± 2.45** 16.40 ± 3.20** 22.18 ± 5.89**
*p < 0.05, **p < 0.01 against control
Table 2. Effects of ribavirin on rat testis. Data are represented as means ± SEM from 5 animals per group. The incidences
of stage XIV tubules decreased significantly at the two higher dose levels on days 14 and 70 (p < 0.01), and at all dose-
levels on day 35 (p < 0.05–0.01) against respective controls. Inter-group differences were significant on days 14, 35
(p < 0.01) and 70 (p < 0.05). A significant increase in sloughing was observed in the first three time points (p < 0.05–0.01).
Inter-group differences were significant up to day 70 (p < 0.01)
Parameter Drug/dose Day 14 Day 35 Day 70 Day 105
Stage XIV tubules (%) Control 4.80 ± 0.37 3.60 ± 0.40 3.80 ± 0.37 3.40 ± 0.51
20 mg/kg 3.80 ± 0.37 1.80 ± 0.37 3.80 ± 0.30 3.00 ± 0.71
100 mg/kg 2.00 ± 0.32 1.00 ± 0.32 1.60 ± 0.40 2.60 ± 0.51
200 mg/kg 1.20 ± 0.37 0.60 ± 0.25 1.61 ± 0.51 2.80 ± 0.58
Tubules with sloughing (%) Control 0 0.20 ± 0.20 0.20 ± 0.20 0.60 ± 0.24
20 mg/kg 0.40 ± 0.24 3.20 ± 0.37 2.60 ± 0.51 0.60 ± 0.24
100mg/kg 4.40 ± 0.51 7.00 ± 0.55 10.00 ± 0.71 0.40 ± 0.24
200 mg/kg 5.20 ± 0.58 7.40 ± 0.51 10.80 ± 0.66 0.80 ± 0.37
Figure 6. The effect of ribavirin on Leydig cell number/inter-tubu-
lar space in the rat. Data are expressed as means ± SEM from
5 animals/group; p < 0.05–0.01, control versus treated and
inter-group differences.
Figure 5. Effect of ribavirin on sperm morphology in the rat.
A. A sperm from 100 mg/kg group with cephalocaudal bending
without fibrils jetting out; B. A sperm from 200 mg/kg group with
cephalocaudal bending with fibrils jetting out (arrows); C. and D.
Microcephalous sperm (arrows) from 20 mg/kg and 100 mg/kg
groups respectively. Note that normal sperm are shown in B and D,
eosin Y, scale bar = 50 µm.
A B C D
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by sloughing. The sloughing of epithelial cells in this
case may be due to damage to intercellular bridges
formed by the microtubules between the Sertoli cells
and the germ cells, although a detailed study is need-
ed to confirm these as effects of ribavirin.
The lack of significant effect on testis weight in-
dicates that severe damage, such as the atrophy of
seminiferous tubules or backflow of exfoliated cells
into the tubules as an aftermath of blockade of the
efferent ductules [14], was not caused by ribavirin.
The drug did not induce the atrophy of seminiferous
tubules at any of the dose-levels or time points stud-
ied. As an indicator of gonadotoxicity, ribavirin af-
fected the STD and SE; the increase in STD on day 14
could be due to the induction of secretion of tubu-
lar fluid, although such an effect of this drug has
not so far been recorded. The decrease in STD and
SE occurred in positive correlation with the slough-
ing of epithelial cells, indicating the shrinkage of
seminiferous tubules as a result of cell loss.
Cytotoxicity was seen in the form of a decreased
incidence of stage XIV tubules. This effect was due
to the prevention of progression of previous stages
of the seminiferous epithelial cycle, especially stag-
es IX–XII, similar to the effects of 1, 3-dinitroben-
zene in the rat [11]. The present findings are, how-
ever, in consensus with previous reports on cyto-
toxicity in rats, in which ribavirin has been found to
decrease the sperm count [15] and step 19 sperma-
tids and to increase cell death [6] and abnormal
sperm [16]. This study adds some other sperm ab-
normalities induced by the drug which have not been
quantified in a previous study [16]. The tail defects
and cephalocaudal junction defects have shown
strong positive correlations with infertility [8]. This sug-
gests that ribavirin might affect the ability of treated
males to fertilise the female rats. Furthermore, the
sperm abnormalities also indicate gross testicular
injury, although various other factors also seem to
be responsible for their formation [16]. The fact that
the fertilizing abilities of both male and female rats
pre-exposed to ribavirin are remains an unresolved
puzzle [1], it may be argued that ribavirin influences
these through structural damage to the testis.
Ribavirin seems to have a moderate but prolonged
effect on testosterone levels in the rat. The lowered
level of the hormone was due to a decreased number
of Leydig cells. Ribavirin showed some cytotoxic ef-
fects on Leydig cells, which resulted in a decrease in
their number. We have not evaluated the effect on
leutinising hormone level in the serum, which must
have only been increased as a result of a negative
feed-back mechanism. Nevertheless, it could be said
that ribavirin functions like an endocrine-disruptor in
the rat. Although a very low level of testosterone in
the testis is sufficient to maintain normal spermato-
genesis [21], an immediate response to its decrease
may be a decrease in parameters such as the number
of advanced spermatids [2]. The decline in weights of
the seminal vesicle and prostate must be due to
a decreased testosterone level, since they are andro-
gen-dependent accessory sex organs [13, 17].
In an interesting study on the in vitro interac-
tion of ribavirin and Leydig cells the former was
able to restore the testosterone level, which was
originally decreased by the mumps virus [10]. This
paves the way for the hypothesis that ribavirin may
not have any effect on the structure or function of
Leydig cells. In fact, the toxicity of ribavirin might
be considerably less in vitro for the simple reason
that ribavirin requires active metabolism to gener-
ate severely toxic metabolites, namely ribavirin 5’
triphosphate and ribavirin 5’ monophosphate, to
impart its toxicity [4, 6, 9]. Hence, lack of metabo-
lism was responsible for the absence of any direct
effect on Leydig cells in vitro [10], therefore not
affecting their function. The restoration of testoster-
one level in the mumps virus-Leydig cells-ribavirin
complex was therefore not due to the direct action
of ribavirin but to the elimination of the virus from
the system by the drug. In this study, however, the
Leydig cells were affected by the drug up to day
105, hence forming a basis for a sustained decrease
of testosterone level in the serum.
Curiously, all the parameters tested here showed
recovery by day 105, except the testosterone level
Figure 7. Effect of ribavirin on serum testosterone level in the
rat. Data are expressed as means ± SEM from 5 animals/group.
Hormone level decreased in a dose-dependent manner (p < 0.05–
–0.01) with significant inter-group differences (p < 0.05–0.01)
except between 100 and 200 mg/kg on days 70 and 105.
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and the number of Leydig cells. Since ribavirin is used
as an aerosol, and occupational exposure may be an
important means of inadvertent exposure, it is note-
worthy that ribavirin has adverse effects on the tes-
tis and other reproductive parameters. It should also
be noted that the drug does not induce atrophy of
the seminiferous tubules, but damages the testis in
a transient fashion and, furthermore, that the endo-
crine-disrupting properties of this drug are prolonged
and disappear at a comparatively slower rate in the
rat testis.
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